Mylan And Biocon Says EMA Accept Its Regulatory Submission Of Biosimilar Pegfilgrastim

By: via Benzinga
Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. revealed that the European Medicines Agency (EMA) has accepted their Marketing Authorization ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.